Bhati Pharmaceuticals (OPC) Private Limited
About Bhati Pharmaceuticals (OPC) Private Limited
Data last updated:
Bhati Pharmaceuticals (OPC) Private Limited is a one person company based in Raipur, Chhattisgarh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 13 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24299CT2021OPC011969. Its GSTIN is 22AAKCB0677P1ZB (Chhattisgarh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹50,000. It is led by director Aasma Parveen.
Its latest financial statements are for the year ended 31 March 2025. The registered office is at 52/1751 Naman Steel Gali Ambedkar Chowk Ashwani Nagar, Raipur, Chhattisgarh, India – 492013.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.42 Lakh, a growth of 33% compared to the previous year. For the same year it recorded a net loss of ₹1,481 (net margin -0.2%) and EBITDA of ₹26,433 (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 87% over three years.
Company details
Contact details
Bhati Pharmaceuticals (OPC) Private Limited's registered office is in Raipur, Chhattisgarh. Its e-mail address is in the company report.
- Email
- Registered Address52/1751 Naman Steel Gali Ambedkar Chowk Ashwani Nagar, Raipur, Chhattisgarh, India – 492013
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Bhati Pharmaceuticals (OPC) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bhati Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Bhati Pharmaceuticals (OPC) Private Limited, buy the company report.
Financials of Bhati Pharmaceuticals (OPC) Private Limited
FY 2025 filings availableBhati Pharmaceuticals (OPC) Private Limited reported revenue of ₹8.42 Lakh (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 87% over three years, including 33% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹26,433 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1,481 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.1% | |||
| Net Profit Margin | -0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bhati Pharmaceuticals (OPC) Private Limited, buy the company report.
Board of directors of Bhati Pharmaceuticals (OPC) Private Limited
Bhati Pharmaceuticals has 1 director on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aasma Parveen | Director | 13 Aug 2021 | 5 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Bhati Pharmaceuticals (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bhati Pharmaceuticals (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bhati Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAKCB0677P1ZB | Chhattisgarh | Active | 20 Dec 2021 |
To see the full GST registrations and return filing status of Bhati Pharmaceuticals (OPC) Private Limited, buy the company report.
Recent activity
Bhati Pharmaceuticals (OPC) Private Limited has 1 board change on record since 2021: 1 appointment. The latest: Aasma Parveen was appointed as Director on 13 Aug 2021.
Frequently asked questions
Bhati Pharmaceuticals is an active company based in Raipur, Chhattisgarh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 13 August 2021 (5+ years old) and is registered under CIN U24299CT2021OPC011969.
Bhati Pharmaceuticals has 1 current director:
- Aasma Parveen - Director
The latest financial statements of Bhati Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Bhati Pharmaceuticals is 22AAKCB0677P1ZB, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Bhati Pharmaceuticals is U24299CT2021OPC011969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bhati Pharmaceuticals was incorporated on 13 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
Aasma Parveen was appointed as Director on 13 Aug 2021.
The registered office of Bhati Pharmaceuticals is at 521751 Naman Steel Gali Ambedkar Chowk Ashwani Nagar, Raipur, Chhattisgarh, India – 492013.
Bhati Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Bhati Pharmaceuticals can be reached at its registered office: 521751 Naman Steel Gali Ambedkar Chowk Ashwani Nagar, Raipur, Chhattisgarh, India – 492013.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
